Press releases

20 January, 2021

Regulatory

Abliva appoints Ellen Donnelly as new CEO as it enters a new stage in its development

Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage biopharmaceutical company developing medicines for the treatment of rare and severe primary mitochondrial diseases, today announced that the Board ...

7 November, 2017

Regulatory

NeuroVive Board Chair Resigns, New Chair Elected

Lund, Sweden, 7 November 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announces that Gregory Batcheller resigned as Chair of the NeuroVive Pharmaceutical AB Board effective ...

4 October, 2017

NeuroVive appoints Daniel Schale as Director of Communications

Lund 4 October 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced the appointment of Daniel Schale as Director of Communicati ...

1 September, 2017

NeuroVive appoints Mark Farmery as Vice President Business Development

Lund, Sweden, September 1, 2017 - NeuroVive Pharmaceutical AB ("NeuroVive" or "the company", Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced the appointment o ...

8 November, 2016

Regulatory

NeuroVive’s recruitment of Michele Tavecchio strengthens its research organization

Lund, Sweden, November 8, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that the company has recruited Michele Tavecchio ...

24 August, 2016

Regulatory

NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company

Lund, Sweden, August 24, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that its Chief Operating Officer, Jan Nilsson lea ...

11 April, 2016

Regulatory

NeuroVive strengthens its organization with the recruitment of Cecilia Hofvander as IR and Communications Director

NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces that it has recruited Cecilia Hofvander as Investor Relations and Communications Director effective from 1 June 2016 i ...

23 February, 2016

Regulatory

Board Selects New CEO Erik Kinnman to Lead NeuroVive

NeuroVive Pharmaceutical AB (publ) board of directors is pleased to announce that it has selected Erik Kinnman as NeuroVive's Chief Executive Officer (CEO). Erik Kinnman will assume the new role on th ...

1 September, 2015

Regulatory

NeuroVive announces departure of CEO and appointment of Jan Nilsson as interim CEO

NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces a change in leadership of the company. Effective today, Mikael Brönnegård will no longer serve as Chief Executive Off ...

8 December, 2014

Regulatory

NeuroVive employs a Clinical Trial Manager

NeuroVive Pharmaceutical AB (publ) has recruited Gunilla Lindgren to the position as Clinical Trial Manager. The recruitment enables NeuroVive to ensure the sustained high quality and efficient operat ...

9 October, 2013

Regulatory

Catharina Johansson appointed new CFO, effective 1 December

NeuroVive Pharmaceutical AB (publ), a leading mitochondrial medicine company, has appointed Catharina Johansson as the company's new CFO. She will take up her position on 1 December. This appointment ...

18 March, 2013

NeuroVive: NeuroVive appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors

Se nyheten från NeuroVive (http://www.aktietorget.se/pressdocs/NeurovivePharmaceutical/64884/NeuroVive__NVP_20130318_2.PDF) Lund (Sweden) - March 18, 2013, NeuroVive Pharmaceutical AB, a leading mitoc ...